PT-141 (Bremelanotide) · Research brief

PT-141 Price — What Research-Grade Vials Actually Cost

Real Peptides Research TeamEditorial

Updated September 16, 202610 min read

60 WORDS

Short answer

Two vials of PT-141 can sit on two supplier pages at the same 10mg label with very different numbers next to them, and the peptide inside is rarely what explains the gap. The PT-141 price difference almost always traces back to what happened before the vial was sealed: how the crude peptide was purified, whether an independent lab tested that…

Key takeaways

The PT-141 price of a research-grade 10mg lyophilized vial typically falls roughly between $25 and $80, and the spread is driven by testing and documentation rather than by the compound.
PT-141 (bremelanotide) is a cyclic heptapeptide requiring a lactam-bridge cyclization step, which makes it more expensive to synthesize and purify than linear research peptides.
HPLC purity and peptide content measure different things; a 98% purity figure says nothing about how much of the vial's mass is actually peptide.
Verified cost per milligram equals vial cost divided by labeled milligrams multiplied by stated peptide content, and it's the only fair comparison between suppliers.
A certificate of analysis is only meaningful when its lot number matches the vial, the analysis is dated, and the raw chromatogram and mass spectrometry data are included.
Research-grade PT-141 is supplied for laboratory use only and is not an approved drug product for human or veterinary use.

At Real Peptides we run small-batch synthesis with exact amino-acid sequencing, and our team checks every lot against its certificate before it moves. Here's what that process has taught us: researchers who compare a PT-141 price vial-to-vial usually overpay. Researchers who compare verified milligram-to-milligram almost never do.

What is the typical PT-141 price?

Research-grade PT-141 (bremelanotide) typically costs roughly $25 to $80 per 10mg lyophilized vial, with domestic suppliers that publish third-party testing clustering toward the upper half of that range. The PT-141 price is set far more by purity verification, peptide content and cold-chain handling than by the raw compound itself. Compare cost per verified milligram.

The common mistake is treating PT-141 price as a single number. It isn't. A 10mg vial certified at 98% HPLC purity with peptide content stated on the certificate delivers measurably more usable compound than an uncertified 10mg vial carrying the same label. What follows covers what drives cost at the manufacturing level, how to convert a quote into real cost per milligram, and how supplier tiers compare on documentation, handling and regulatory standing.

What you're actually paying for inside the vial

PT-141, also called bremelanotide, is a cyclic heptapeptide and a synthetic analogue of alpha-melanocyte-stimulating hormone (alpha-MSH) that acts as a melanocortin receptor agonist, with reported activity at the MC1R, MC3R and MC4R receptors. That structure has direct cost consequences. The PT-141 price reflects a cyclization step that linear research peptides don't require: the sequence is closed through a lactam bridge between side chains, which adds synthesis steps, lowers crude yield, and demands tighter reversed-phase HPLC purification to separate the cyclic product from open-chain and deletion-sequence impurities.

Then everything downstream stacks on top. Lyophilization under vacuum into a stable cake. Independent analytical testing, meaning HPLC for purity and mass spectrometry to confirm a molecular ion consistent with bremelanotide. Lot-specific documentation. Insulated packaging with cold packs so the vial isn't sitting at ambient temperature for two weeks in transit.

Remove any one of those and the number drops. That's the entire mechanism behind a bargain quote. A supplier who skips independent verification and ships in a padded envelope can undercut a tested vial substantially, and nothing on the product page announces it.

Our team has reviewed incoming lots against their certificates for years, and the pattern repeats: the widest quality gaps appear in exactly the tier where the PT-141 price looks too attractive to interrogate.

Cost per verified milligram: the math most buyers skip

Compare cost per verified milligram, not cost per vial. A 10mg vial and a 5mg vial at the same nominal purity are not comparable products, and the PT-141 price on a listing tells you nothing until it's divided by the peptide the vial genuinely contains.

Here's the part most sourcing guides get wrong. Purity and peptide content are two separate measurements, and only one of them is usually advertised. HPLC purity describes what fraction of the peptide present is the correct sequence. Peptide content describes what fraction of the vial's total mass is peptide at all. The remainder is counterion, commonly trifluoroacetate left over from HPLC purification, plus residual water and salts. A certificate can honestly report 98% HPLC purity on a powder whose net peptide content is meaningfully lower, because those two numbers answer completely different questions.

The arithmetic is straightforward once both numbers exist. Nominal cost per milligram is vial price divided by labeled milligrams. Verified cost per milligram is vial price divided by labeled milligrams multiplied by peptide content. If one supplier publishes peptide content and another doesn't, you aren't comparing two prices, you're comparing a measured value against an assumption. That's how a lower PT-141 price per vial quietly becomes the higher cost per usable milligram.

Reading the certificate before you compare quotes

A PT-141 price quoted without a matching certificate of analysis is an estimate, not a price. The certificate is where a number becomes verifiable, and a usable one contains specific elements rather than a single purity claim on a letterhead:

A lot or batch number that matches what's printed on the vial you receive
An analysis date, not only a document issue date
The HPLC chromatogram itself, not a summary line asserting a percentage
Mass spectrometry data confirming a molecular ion consistent with bremelanotide's molecular weight of roughly 1,025 g/mol
Peptide content expressed as a percentage of total vial mass
Sterility and endotoxin results where the intended laboratory application calls for them

Handling belongs in the same conversation, because it protects the value you paid for. Lyophilized peptide is generally stored at -20°C and protected from light; once reconstituted, material is refrigerated at 2°C to 8°C under the laboratory's own standard operating procedure, and repeated freeze-thaw cycling degrades peptide integrity regardless of starting purity.

One regulatory distinction matters here. Bremelanotide is the active ingredient in a prescription product that holds FDA approval for a specific clinical indication in humans. Research-grade PT-141 is not that product. It is supplied for laboratory research use only, is not an approved drug, and is not for human or veterinary consumption. This article is research education, not medical guidance. Anyone with questions about their own health should speak with a licensed physician, and anyone with questions about an animal's health should talk to their veterinarian.

PT-141 price comparison across supplier tiers

This table maps how PT-141 price tracks against documentation, traceability and handling. It's the fastest way to see why two identical-looking vials aren't comparable purchases.

Source type	Typical price signal per 10mg vial	Documentation you can expect	Handling and shipping	Bottom line
Offshore bulk reseller	Lowest, often roughly $15 to $30	In-house certificate, frequently undated or not tied to the vial's lot number	Ambient postal transit, often multiple weeks	Cheapest on paper and unverifiable in practice; verified cost per milligram cannot be calculated at all
Domestic supplier with third-party testing	Mid to upper, roughly $40 to $80	Independent HPLC and mass spectrometry report matched to a lot number, with peptide content stated	Insulated packaging with cold packs, short domestic transit	Highest verified value per milligram and the only tier where a researcher can actually check the math
Social or marketplace listing	Highly variable, occasionally below plausible synthesis cost	Often a copied PDF from an unrelated batch, or nothing	Unknown, no chain of custody	No traceability from synthesis to delivery; not a defensible research supply line
Prescription bremelanotide	Set by pharmacy and insurance, substantially higher	Full approved-product labeling and pharmacy records	Pharmacy-controlled distribution	A regulated human medicine prescribed by a clinician, not a laboratory research supply route

What If: Sourcing and Pricing Scenarios

What if two suppliers list the same 10mg vial at wildly different prices?

Request both certificates of analysis before ordering anything. The PT-141 price gap between two identical labels is usually explained by one of four things: no independent testing, no stated peptide content, ambient shipping instead of cold-pack transit, or a certificate that belongs to a different lot. Ask each supplier for the chromatogram and the lot number printed on the vial. A supplier who can produce both within a day is doing the work the higher number pays for. A supplier who sends a purity claim with no supporting data is selling an assertion.

What if the certificate has no lot number or analysis date?

Treat that document as marketing material rather than documentation. A certificate without a lot number cannot be tied to the vial in your hand, which means the purity figure describes some batch, somewhere, at some point. Analytical results are batch-specific because synthesis yield, purification efficiency and residual solvent all vary between runs. Undated certificates also hide whether the analysis was performed on the current lot or recycled from an earlier one. Ask for a lot-matched replacement before purchase, and if it doesn't exist, the quoted cost per milligram is unknowable.

What if a vial arrives warm after a delayed shipment?

Photograph the packaging and cold packs on arrival, then contact the supplier before opening the vial. Lyophilized peptide is considerably more tolerant of brief ambient excursions than reconstituted solution, because removing water slows the hydrolysis and aggregation pathways that degrade peptides in liquid form. That tolerance is not unlimited. Prolonged heat exposure or repeated temperature cycling can affect integrity in ways that visual inspection cannot detect, and no home or bench check substitutes for analytical testing. Document the condition and let the supplier's shipping policy decide the outcome.

What if the lyophilized cake looks cracked, shrunken or stuck up the side of the vial?

Record the appearance and query the lot with the supplier. Cake structure depends on the lyophilization cycle, fill volume and vial orientation during freeze-drying, so a thin, cracked or partly climbing cake is sometimes cosmetic and sometimes not. A collapsed or melted-back cake is more concerning, because it can indicate the product rose above its glass transition temperature during drying or transit. Appearance alone cannot confirm or rule out potency, which is precisely why the lot-matched certificate carries more weight than what the vial looks like.

What if a listing is dramatically cheaper than everything else on the market?

Assume the difference is testing and traceability, not a supplier being generous. Independent HPLC and mass spectrometry on every lot, peptide content determination, insulated shipping and proper cold storage all carry real per-vial cost, and no volume discount erases them entirely. When a listing sits far below the market, something in that chain was removed. The honest question isn't whether it's cheaper, it's which verification step you're no longer paying for.

The unflattering truth about the cheapest listings

Let's be direct about this: below a certain point, you're not buying a discount on PT-141, you're buying an unverified powder in a labeled vial. The lowest PT-141 price in any search result is almost never a manufacturing efficiency. It's an omission, usually the third-party analytical report, sometimes the peptide content determination, occasionally both plus the cold chain. A vial with no traceable certificate has no known concentration, which makes every downstream result in the lab unattributable. Cheap material doesn't produce cheap research. It produces research you can't defend.

Researchers comparing suppliers can review our PT-141 (bremelanotide) product page for current specifications, read the broader PT-141 research overview for background on the melanocortin pathway, and check lot-matched analytical data in our certificates of analysis library. Common sourcing and handling questions are answered in the PT-141 FAQ, the wider catalog sits in our research peptide shop, and shipping and facility details are outlined on our location page.

The PT-141 price that ends up being the true bargain is rarely the lowest one on the page, and the reason is almost boring: peptides are sold by weight but used by concentration, and only a lot-matched certificate connects those two things. Everything else in the transaction is packaging. When a supplier hands you a chromatogram, a mass spectrum and a peptide content figure, they've handed you the ability to calculate what you actually bought. When they hand you a percentage and nothing behind it, the number on the invoice was never the real cost.

References

Peer-reviewed sources on PT-141 (Bremelanotide) indexed in PubMed, listed for research context. Real Peptides supplies PT-141 (Bremelanotide) for laboratory research use only.

Small Effects, Questionable Outcomes: Bremelanotide for Hypoactive Sexual Desire Disorder. Journal of sex research, 2024. PMID 36809187. doi:10.1080/00224499.2023.2175192
An evaluation of bremelanotide injection for the treatment of hypoactive sexual desire disorder. Expert opinion on pharmacotherapy, 2023. PMID 36242769. doi:10.1080/14656566.2022.2132144
Bremelanotide for Treatment of Female Hypoactive Sexual Desire. Neurology international, 2022. PMID 35076581. doi:10.3390/neurolint14010006
The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women. CNS spectrums, 2022. PMID 33455598. doi:10.1017/S109285292100002X
Safety Profile of Bremelanotide Across the Clinical Development Program. Journal of women's health (2002), 2022. PMID 35147466. doi:10.1089/jwh.2021.0191
Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide. Journal of women's health (2002), 2022. PMID 35230162. doi:10.1089/jwh.2021.0225
Re-Analyzing Phase III Bremelanotide Trials for "Hypoactive Sexual Desire Disorder" in Women. Journal of sex research, 2021. PMID 33678061. doi:10.1080/00224499.2021.1885601
Bremelanotide and flibanserin for low sexual desire in women: the fallacy of regulatory precedent. Drug and therapeutics bulletin, 2021. PMID 34642243. doi:10.1136/dtb.2021.000020

Questions

Research-grade PT-141 (bremelanotide) typically costs roughly $25 to $80 for a 10mg lyophilized vial, with 5mg vials priced lower and multi-vial orders reducing the per-vial figure. Suppliers that publish independent HPLC and mass spectrometry results for every lot generally sit in the upper half of that range. The spread reflects analytical testing, peptide content verification and cold-chain shipping rather than differences in the compound itself.

The PT-141 price varies because suppliers include different things in it. Third-party HPLC purity testing, mass spectrometry confirmation, peptide content determination, lot-specific certificates and insulated cold-pack shipping all carry real per-vial cost. A supplier who skips independent verification and ships at ambient temperature can undercut a fully tested vial substantially, and the listing page rarely discloses which steps were removed.

Divide the vial cost by the labeled milligrams to get nominal cost per milligram, then divide again by the stated peptide content percentage to get verified cost per milligram. Peptide content matters because part of a lyophilized vial's mass is counterion such as trifluoroacetate, residual water and salts rather than peptide. If a supplier doesn't publish peptide content, the verified figure cannot be calculated and you're comparing against an assumption.

Research-grade PT-141 is supplied to researchers, laboratories and institutions for in-vitro and laboratory research use only. It is not sold for human or veterinary consumption and is not an approved drug product. Buyers are responsible for handling the material under their own laboratory standard operating procedures and applicable local regulations.

Not necessarily lower purity, but almost always less verification. A low price usually means the supplier omitted independent analytical testing, peptide content determination, or temperature-controlled shipping. Without a lot-matched certificate of analysis, purity is an unsupported claim rather than a measured result, which means the material's actual concentration is unknown regardless of what the label says.

They share the same peptide, bremelanotide, but they are entirely different products in regulatory terms. Prescription bremelanotide is an FDA-approved medicine supplied through pharmacies under clinician direction, with full approved labeling and pharmacy-controlled distribution. Research-grade PT-141 is a laboratory reagent supplied with a certificate of analysis for research use only, is not approved for any human or animal use, and costs a fraction of the pharmacy route because it is a different category of product entirely.

A usable certificate includes a lot or batch number matching the vial, an analysis date, the HPLC chromatogram rather than a summary purity figure, mass spectrometry data confirming a molecular ion consistent with bremelanotide's molecular weight of roughly 1,025 g/mol, and peptide content as a percentage. Sterility and endotoxin results are relevant for some laboratory applications. A certificate without a matching lot number cannot be tied to the vial you received.

Yes, and it is one of the most common hidden differences between quotes. Insulated packaging, cold packs and short domestic transit all add per-shipment cost that ambient postal delivery avoids. Lyophilized peptide tolerates brief ambient excursions better than reconstituted solution, but prolonged heat exposure during multi-week transit can affect integrity in ways no visual inspection detects.

Lyophilized PT-141 is generally stored at -20°C, protected from light and moisture, in its sealed vial. Once reconstituted, material is typically refrigerated at 2°C to 8°C under the laboratory's own standard operating procedure. Repeated freeze-thaw cycling degrades peptide integrity regardless of the starting purity, so aliquoting is standard practice for stored solutions.

Usually yes, because packaging, documentation and cold-shipping costs are spread across more vials in a single shipment. The saving is genuine only when every vial in the order comes from a tested lot with its own matching certificate. A volume discount on undocumented material lowers the invoice without lowering the verified cost per milligram, since the verified figure cannot be calculated at all.

Bremelanotide is the active ingredient in a prescription product that holds FDA approval for a specific clinical indication in humans. Research-grade PT-141 sold for laboratory use is not that product, is not an approved drug, and is not intended for human or veterinary consumption. Anyone with health questions should speak with a licensed physician, and anyone with questions about an animal should talk to their veterinarian.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA